IL257188A - Pharmaceutical composition with improved storage stability and method for preparing the same - Google Patents

Pharmaceutical composition with improved storage stability and method for preparing the same

Info

Publication number
IL257188A
IL257188A IL257188A IL25718818A IL257188A IL 257188 A IL257188 A IL 257188A IL 257188 A IL257188 A IL 257188A IL 25718818 A IL25718818 A IL 25718818A IL 257188 A IL257188 A IL 257188A
Authority
IL
Israel
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
IL257188A
Other languages
Hebrew (he)
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of IL257188A publication Critical patent/IL257188A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL257188A 2015-07-28 2018-01-28 Pharmaceutical composition with improved storage stability and method for preparing the same IL257188A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106627 2015-07-28
PCT/KR2016/008267 WO2017018818A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
IL257188A true IL257188A (en) 2018-03-29

Family

ID=57885186

Family Applications (1)

Application Number Title Priority Date Filing Date
IL257188A IL257188A (en) 2015-07-28 2018-01-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Country Status (13)

Country Link
EP (1) EP3328435A4 (en)
JP (1) JP2018521103A (en)
KR (1) KR101787451B1 (en)
CN (1) CN106659681A (en)
AU (1) AU2016299546B2 (en)
BR (1) BR112018001725A2 (en)
CA (1) CA2993925A1 (en)
HK (1) HK1249442A1 (en)
IL (1) IL257188A (en)
MX (1) MX2018001221A (en)
RU (1) RU2018107057A (en)
WO (1) WO2017018818A1 (en)
ZA (1) ZA201801188B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102144479B1 (en) * 2018-05-24 2020-08-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
KR102251192B1 (en) * 2020-08-07 2021-05-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550157B2 (en) * 2000-05-12 2009-06-23 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
US7879317B2 (en) * 2001-10-18 2011-02-01 Samyang Corporation Polymeric micelle compositions with improved stability and methods of making thereof
ATE487134T1 (en) 2007-03-06 2010-11-15 Cell Therapeutics Europe Srl METHOD FOR DETERMINING THE AMOUNT OF CONJUGATED TAXANS IN POLYGLUTAMIC ACID-TAXANE CONJUGATES
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
CA2709967C (en) * 2007-12-31 2012-05-29 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN102218027B (en) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 Polymer micelle lyophilized agent encapsulating insoluble antitumor drug
CN103768013A (en) * 2014-01-17 2014-05-07 丽珠医药集团股份有限公司 Paclitaxel polymer micelle by using refined amphiphilic block copolymer as carrier

Also Published As

Publication number Publication date
RU2018107057A3 (en) 2019-08-28
AU2016299546A1 (en) 2018-03-08
RU2018107057A (en) 2019-08-28
AU2016299546B2 (en) 2019-05-02
WO2017018818A1 (en) 2017-02-02
JP2018521103A (en) 2018-08-02
CN106659681A (en) 2017-05-10
KR20170015199A (en) 2017-02-08
HK1249442A1 (en) 2018-11-02
BR112018001725A2 (en) 2018-09-18
EP3328435A1 (en) 2018-06-06
ZA201801188B (en) 2018-12-19
CA2993925A1 (en) 2017-02-02
EP3328435A4 (en) 2019-03-13
MX2018001221A (en) 2018-04-24
KR101787451B1 (en) 2017-10-19

Similar Documents

Publication Publication Date Title
IL289099A (en) Methods for the storage of whole blood, and compositions thereof
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
IL251703B (en) Pharmaceutical composition with improved stability
ZA201703398B (en) Pharmaceutical composition and methods
HRP20200104T8 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
HK1214767A1 (en) Tablet-formed pharmaceutical composition and preparation method thereof
IL257621B (en) Novel catechol derivatives and pharmaceutical composition comprising the same
HK1249439A1 (en) Pharmaceutical composition with improved storage stability and method for preparing the same
HK1249442A1 (en) Pharmaceutical composition with improved storage stability and method for preparing the same
EP3384933C0 (en) Anhydrosugar alcohol composition having enhanced storage stability, and anhydrosugar alcohol storage method
EP3305283A4 (en) Stabilized pharmaceutical composition and method for preparing same
PT3250188T (en) Pharmaceutical composition comprising aprepitant and method for the preparation thereof
HK1249440A1 (en) Pharmaceutical composition with improved storage stability and method for preparing the same
HK1249441A1 (en) Pharmaceutical composition with improved storage stability and method for preparing the same
PL3324971T3 (en) Zolpidem composition and process for preparing the same
EP3344661C0 (en) Iron-polysaccharide complexes and methods for the preparation thereof
IL230801A0 (en) Stable sulfur-containing solid composition and method for manufacturing the same